Retinoic acid protects against hyperoxia-mediated cell-cycle arrest of lung alveolar epithelial cells by preserving late G1 cyclin activities

Am J Respir Cell Mol Biol. 2001 Oct;25(4):507-14. doi: 10.1165/ajrcmb.25.4.4478.

Abstract

The epithelium of the lung alveolus is a major target for oxidant injury, and its proper repair after injury is dependent on the proliferative response of the alveolar epithelial type 2 cells. Recently, we have provided evidence that retinoic acid (RA) stimulates proliferation of type 2 cells. In the present study, we examined the effects of RA on the proliferative response of alveolar type 2 cells exposed to elevated oxygen (O(2)). We showed that pretreatment by RA was able to prevent the growth arrest and cell loss of O(2)-exposed cells. To gain insights into the mechanisms involved, we studied the effects of RA on the cyclin-dependent kinase (CDK) system. The activity of cyclin E-CDK2 complex was found to be decreased in O(2)-exposed cells. Interestingly, this decrease was no longer observed when cells were pretreated with RA. Analysis of p21(CIP1), an inhibitor of CDK, revealed an increased expression in O(2)-exposed cells that was no longer observed in cells treated with RA. These effects were associated with a reduced association of p21(CIP1) with cyclin E-CDK2 complexes in the presence of RA. In addition, studies of Smad activity strongly suggest that the mechanisms through which RA preserves late G(1) cyclin-CDK complex activity may involve interference with the transforming growth factor-beta signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CDC2-CDC28 Kinases*
  • Cell Cycle / drug effects*
  • Cell Division / drug effects
  • Cells, Cultured
  • Cyclin E / drug effects
  • Cyclin E / metabolism
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclin-Dependent Kinases / drug effects
  • Cyclin-Dependent Kinases / metabolism
  • Cyclins / drug effects
  • Cyclins / metabolism*
  • G1 Phase / drug effects
  • G1 Phase / physiology
  • Hyperoxia / drug therapy
  • Hyperoxia / prevention & control*
  • Oxygen / metabolism
  • Oxygen / pharmacology
  • Protein Serine-Threonine Kinases / drug effects
  • Protein Serine-Threonine Kinases / metabolism
  • Pulmonary Alveoli / cytology*
  • Pulmonary Alveoli / drug effects
  • Pulmonary Alveoli / metabolism
  • Rats
  • Respiratory Mucosa / cytology*
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / metabolism
  • Signal Transduction
  • Transforming Growth Factor beta / drug effects
  • Transforming Growth Factor beta / metabolism
  • Tretinoin / pharmacology*

Substances

  • Cdkn1a protein, rat
  • Cyclin E
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Transforming Growth Factor beta
  • Tretinoin
  • Protein Serine-Threonine Kinases
  • CDC2-CDC28 Kinases
  • Cdk2 protein, rat
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinases
  • Oxygen